24 May 2013
Keywords: biomarin, starts, ph, iii, trial, phenoptin, pharmaceutical
Article | 18 April 2005
BioMarin Pharmaceutical of the USA says it has randomized the first patient in its Phase III clinical trial of Phenoptin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 April 2005
23 May 2013
© 2013 thepharmaletter.com